MedPath

Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population

Completed
Conditions
Gastric Cancer
Registration Number
NCT04019808
Lead Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Brief Summary

This study is divided into two parts:

Part 1: An interventional study, with a pre-post study design to determinate the grade of knowledge of established GC risk factors.

Part 2: An observational study to know impact on prevalence and infection eradication of H. pylori

Detailed Description

Part 1: to determinate the grade of knowledge of established GC risk factors and identification of attitudes about, GC screening programs at baseline, prior to the intervention though an educational program.

Part 2: to generate an H. pylori registry, to know its impact on prevalence and infection eradication rate at 6th, 12th, 24th and at Month 36th.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
800
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
knowledge GC risk factors and symptoms3 years

Compare the results obtained through a knowledge of CG risk factors by study-specific questionnaire before and after an educational intervention

H. pylori prevalence and drug resistance3 years

Generate an H. pylori registry, to know its impact on prevalence and infection eradication rate at months 6th, 12th, 24th and 36th.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (8)

Instituto Alexander Fleming

🇦🇷

Buenos Aires, Argentina

Pontificia Universidad Católica de Chile

🇨🇱

Santiago, Chile

Instituto Nacional de Cancerología

🇲🇽

Mexico, Mexico

VU Medical Centre

🇳🇱

Amsterdam, Netherlands

GenPat

🇵🇾

Asunción, Paraguay

Institute of Pathology and Immunology of University of Porto

🇵🇹

Porto, Portugal

Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron (VHIO)

🇪🇸

Barcelona, Spain

Fundación Investigación Clínico de Valencia

🇪🇸

Valencia, Spain

Instituto Alexander Fleming
🇦🇷Buenos Aires, Argentina

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.